Quality Management Optimizing HEDIS & STARSMedicare AdvantageApril 2, 2025

HEDIS measure: Statin Use in Persons with Diabetes (SUPD) 2025

Measure

This HEDIS® measure assesses the percentage of members with diabetes who take the most effective cholesterol lowering drugs to lower their risk of developing heart disease.

Refer to attachment to view full details

HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA).

CarelonRx, Inc. is an independent company providing pharmacy benefit management services on behalf of the health plan.

Anthem BC Health Insurance Company is the trade name of Anthem Insurance Companies, Inc. Anthem Blue Cross is the trade name of Blue Cross of California. Anthem Blue Cross, Anthem Blue Cross Life and Health Insurance Company, and Anthem BC Health Insurance Company are independent licensees of the Blue Cross Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

MULTI-BC-CR-075413-24-CPN74739

ATTACHMENTS: HEDIS measure: Statin Use in Persons with Diabetes (SUPD) 2025 (pdf - 0.13mb)